Transforming antibodies in Washington DC

Posted on: Saturday, December 7th, 2024

Israel’s Biolojic Design (see here previously) is joining the Johnson & Johnson Innovation – JLABS (JLABS) to develop therapeutic antibodies at its Washington, D.C. site. JLABS is one of the largest global networks of incubators pioneering groundbreaking healthcare solutions.